ICT&health December 1, 2021
Artur Olesch

Apps on prescriptions in Germany (DiGA) have their supporters and opponents. One year after introducing a novel legal framework, some celebrate 24 accepted digital health apps and 50.000 prescriptions. Others say the model is unsustainable – the share of DiGA prescriptions in the total number of prescriptions is 0,125%. What went wrong? We’ve talked to Sven Jungmann, a doctor by education and Chief Medical Officer and Partner at FoundersLane.

How do you evaluate the introduction of DiGA on the German healthcare market? What went well, and what went wrong?

Looking at the early versions of the official reasoning behind the DiGA, you will find that the people behind the DiGA initially were very soft on requirements regarding the evidence...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, Interview / Q&A, Patient / Consumer, Provider, Technology, Trends
Emirates improves in-flight digital medical care
Ensuring HIPAA Compliance in Telehealth Sessions
Five benefits of a health tech accelerator program
How leveraging cardiac data via RPM can help overcome many clinical challenges
Building A Resilient Digital Infrastructure For Global Enterprises: A Holistic Approach To Transformation

Share This Article